SHAREHOLDER INVESTIGATION REMINDER: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Aquestive TherapeuticsNewsfile Corp • 02/05/26
INVESTOR ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Aquestive TherapeuticsGlobeNewsWire • 02/04/26
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Aquestive Therapeutics, Inc. - AQSTGlobeNewsWire • 02/03/26
AQST Investors Have Opportunity to Join Aquestive Therapeutics, Inc. Fraud Investigation with the Schall Law FirmBusiness Wire • 02/02/26
What's Going On With Aquestive Therapeutics Stock After FDA Update For Lead Allergic Treatment?Benzinga • 02/02/26
Aquestive Therapeutics, Inc. (AQST) Discusses FDA Complete Response Letter and Next Steps for Anaphylm Epinephrine Sublingual Film TranscriptSeeking Alpha • 02/02/26
Aquestive Therapeutics Announces FDA Issuance of Complete Response Letter for Anaphylm™GlobeNewsWire • 02/02/26
Shareholders Alert: Investigation Into Aquestive Therapeutics, Inc. (AQST) - Contact Levi & Korsinsky to Protect Your RightsNewsfile Corp • 02/02/26
Investigation Underway: Aquestive Therapeutics, Inc. (AQST) - Contact Levi & Korsinsky Over Securities Law ViolationsNewsfile Corp • 01/26/26
INVESTIGATION ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Aquestive TherapeuticsPRNewsWire • 01/26/26
AQUESTIVE ALERT: Bragar Eagel & Squire, P.C. is Investigating Aquestive Therapeutics, Inc. on Behalf of Aquestive Stockholders and Encourages Investors to Contact the FirmGlobeNewsWire • 01/20/26
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims on Behalf of Investors of Aquestive Therapeutics, Inc. - AQSTGlobeNewsWire • 01/20/26
Ongoing Securities Investigation into Aquestive Therapeutics, Inc. (AQST) - Contact Levi & KorsinskyNewsfile Corp • 01/19/26
Here's Why Aquestive Therapeutics (AQST) Is a Great 'Buy the Bottom' Stock NowZacks Investment Research • 01/14/26
Levi & Korsinsky Investigates Possible Securities Fraud by Aquestive Therapeutics, Inc. (AQST)Newsfile Corp • 01/14/26
Aquestive Therapeutics Investors Who Have Lost Money Should Contact Block & Leviton to Find Out How They Might Recover Money Through the Firm's InvestigationNewsfile Corp • 01/13/26
Aquestive Therapeutics: Anaphylm Will Probably Survive This Regulatory HurdleSeeking Alpha • 01/13/26
Down 37% in 4 Weeks, Here's Why Aquestive Therapeutics (AQST) Looks Ripe for a TurnaroundZacks Investment Research • 01/12/26
INVESTOR ALERT: Investigation of Aquestive Therapeutics, Inc. (AQST) by Holzer & Holzer, LLCGlobeNewsWire • 01/09/26
BREAKING: Aquestive Therapeutics Investigated for Securities Fraud After FDA Identifies Deficiencies; Investors Should Contact Block & Leviton To Potentially Recover LossesGlobeNewsWire • 01/09/26
Aquestive Therapeutics Announces Regulatory Development for Anaphylm™ (dibutepinephrine) Sublingual Film and Provides Business UpdateGlobeNewsWire • 01/09/26